tiprankstipranks
Mindset Pharma Inc. (TSE:MSET)
CNQX:MSET

Mindset Pharma Inc. (MSET) Stock News & Sentiment

5 Followers
Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds
PremiumPress Releases
Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds
1y ago
Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023
PremiumPress Releases
Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023
1y ago
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics
PremiumPress Releases
Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics
1y ago

News Score - Last 7 Days

Neutral
TSE:MSET
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MSET’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:MSET’s weekly average amount of articles?
Currently, no data Available
What is TSE:MSET’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
RVTYRevvity
UTHRUnited Therapeutics
SRPTSarepta Therapeutics
MDXGMiMedx Group
NHTCNatural Health Trends
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis